COX11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.098400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.568400E-01
Normal-vs-Stage2
6.932200E-01
Normal-vs-Stage3
9.960300E-02
Normal-vs-Stage4
4.659000E-01
Stage1-vs-Stage2
3.610300E-02
Stage1-vs-Stage3
6.798000E-02
Stage1-vs-Stage4
2.021600E-01
Stage2-vs-Stage3
2.285800E-01
Stage2-vs-Stage4
8.517000E-01
Stage3-vs-Stage4
1.604810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.279600E-01
Normal-vs-AfricanAmerican
9.424000E-01
Normal-vs-Asian
4.639600E-01
Caucasian-vs-AfricanAmerican
8.370000E-01
Caucasian-vs-Asian
2.644000E-01
AfricanAmerican-vs-Asian
3.315600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.320400E-01
Normal-vs-Female
9.989200E-01
Male-vs-Female
4.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.597200E-01
Normal-vs-Age(41-60Yrs)
9.375800E-01
Normal-vs-Age(61-80Yrs)
8.376600E-01
Normal-vs-Age(81-100Yrs)
7.839800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.359800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.555400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.022600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.139600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.571200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.390800E-01
Normal-vs-Daily Drinker
2.607600E-01
Normal-vs-Weekly Drinker
7.851600E-01
Normal-vs-Occasional Drinker
7.051600E-01
Normal-vs-Social Drinker
9.916800E-01
Non Drinker-vs-Daily Drinker
6.830200E-01
Non Drinker-vs-Weekly Drinker
5.373000E-01
Non Drinker-vs-Occasional Drinker
7.433800E-02
Non Drinker-vs-Social Drinker
1.419390E-01
Daily Drinker-vs-Weekly Drinker
4.293600E-01
Daily Drinker-vs-Occasional Drinker
5.877600E-02
Daily Drinker-vs-Social Drinker
8.315800E-02
Weekly Drinker-vs-Occasional Drinker
2.823800E-01
Weekly Drinker-vs-Social Drinker
6.298800E-01
Occasional Drinker-vs-Social Drinker
4.028200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.400790E-01
Normal-vs-Grade 2
2.912100E-02
Normal-vs-Grade 3
8.664900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.421190E-01
Grade 1-vs-Grade 3
1.020780E-01
Grade 1-vs-Grade 4
1.400790E-01
Grade 2-vs-Grade 3
6.521000E-01
Grade 2-vs-Grade 4
2.912100E-02
Grade 3-vs-Grade 4
8.664900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.197800E-01
Normal-vs-NonDiabetic
9.881000E-01
Diabetic-vs-NonDiabetic
2.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.388600E-01
Normal-vs-NoPancreatitis
9.770000E-01
Pancreatitis-vs-NoPancreatitis
1.768380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.144400E-01
Normal-vs-N1
7.065400E-01
N0-vs-N1
1.809990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.017000E-01
Normal-vs-TP53-NonMutant
6.503400E-01
TP53-Mutant-vs-TP53-NonMutant
1.462380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
